![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication July 7, 2005.
Revised October 14, 2005.
Accepted for publication October 14, 2005.
-induced tracheal contraction, involving NO release and expression of cGMP and PKG
KMUP-3 (7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) was investigated in guinea-pig tracheal smooth muscle (TSM). Intra-tracheal instillation of TNF-
(0.01 mg/kg/300 µl) induced bronchoconstriction, increases of lung resistance and decreases of dynamic lung compliance. Instillation of KMUP-3 (0.5-2.0 mg/kg) reversed this situation. In isolated trachea precontracted with carbachol, KMUP-3 (10-100 µM) caused relaxations were attenuated by epithelium removal and by pretreatments with an inhibitor of K+ channel, tetraethylammonium (TEA, 10 mM); KATP channel, glibenclamide (1 µM); voltage-dependent K+ channel, 4-aminopyridine (4-AP, 100 µM); Ca2+-dependent K+ channel, charybdotoxin (ChTX, 0.1 µM) or apamin (1 µM); soluble guanylate cyclase (sGC), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 1 µM); nitric oxide (NO) synthase, N
-nitro-l-arginine methyl ester (L-NAME, 100 µM); adenylate cyclase, 9-(terahydro-2-furanyl) -9H-purin-6-amine (SQ 22536, 100 µM). KMUP-3 (0.01-100 µM) induced increases of cGMP and cAMP in primary culture of tracheal smooth muscle cells (TSMCs). The increase in cGMP by KMUP-3 was reduced by ODQ and L-NAME; the increase in cAMP was reduced by SQ 22536. Western blot analysis indicated that KMUP-3 (1 µM) induced expression of PKARI and PKG1
1
in TSMC. SQ 22536 inhibited KMUP-3-induced expression of PKARI. On the contrary, ODQ inhibited KMUP-3-induced expression of PKG1
1
. In epithelium-intact trachea, KMUP-3 increased the NO release. Activation of sGC, NO release, and inhibition of phosphodiesterases (PDEs) in TSMC by KMUP-3 may result in increases of intracellular cGMP and cAMP, which subsequently activate PKG and PKA, efflux of K+ ion and associated reduction in Ca2+ influx in vitro, indicating the action mechanism to protect against TNF-
-induced airway dysfunction in vivo.
Key words:
KMUP-3, PDE inhibition, cGMP/cAMP, epithelium-dependent, protein kinase G/protein kinase A, tracheal smooth muscle relaxation
This article has been cited by other articles:
![]() |
B.-N. Wu, C.-W. Chen, S.-F. Liou, J.-L. Yeh, H.-H. Chung, and I.-J. Chen Inhibition of Proinflammatory Tumor Necrosis Factor-{alpha}-Induced Inducible Nitric-Oxide Synthase by Xanthine-Based 7-[2-[4-(2-Chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in Rat Trachea: The Involvement of Soluble Guanylate Cyclase and Protein Kinase G Mol. Pharmacol., September 1, 2006; 70(3): 977 - 985. [Abstract] [Full Text] [PDF] |
||||